financetom
Business
financetom
/
Business
/
-- Keyera Brief: Keeps Sector Perform But Target Edges Up To C$39 From $38 at National Bank After Q3; Says "Growth Nearing FID As Frac Capacity Tightens Up"
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
-- Keyera Brief: Keeps Sector Perform But Target Edges Up To C$39 From $38 at National Bank After Q3; Says "Growth Nearing FID As Frac Capacity Tightens Up"
Nov 15, 2024 7:50 AM

10:12 AM EST, 11/15/2024 (MT Newswires) --

Price: 44.48, Change: +0.01, Percent Change: +0.02

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enerflex Provides Preliminary 2025 Outlook
Enerflex Provides Preliminary 2025 Outlook
Jan 13, 2025
06:54 AM EST, 01/13/2025 (MT Newswires) -- Enerflex ( EFXT ) on Monday provided its preliminary outlook for 2025 that reflects steady demand across its business lines and geographic regions. The company projects total capital expenditures of US$110 million to US$130 million, including US$70 million for maintenance and property, plant and equipment capex. The fundamentals for contract compression in the...
i-80 Gold Down 3% In US Premarket As Announces Proposed Amendments to its Convertible Debentures
i-80 Gold Down 3% In US Premarket As Announces Proposed Amendments to its Convertible Debentures
Jan 13, 2025
06:55 AM EST, 01/13/2025 (MT Newswires) -- i-80 GOLD CORP. ( IAUX ) was at last look down more than 3% in US premarket trade after announcing Monday that it has reached an agreement with certain convertible debenture holders to implement proposed amendments to the terms of its convertible debentures, which are expected to assist in the second phase of...
Gilead Sciences Partners With LEO Pharma on Inflammatory Disease Therapies
Gilead Sciences Partners With LEO Pharma on Inflammatory Disease Therapies
Jan 13, 2025
06:53 AM EST, 01/13/2025 (MT Newswires) -- Gilead Sciences ( GILD ) is acquiring LEO Pharma's STAT6 program for the potential treatment of patients with inflammatory diseases for up to $1.7 billion, including an upfront payment of $250 million, as part of a partnership agreement, the companies said Saturday. Under the terms of the deal, Gilead will acquire LEO Pharma's...
Exclusive-Berlin considers full Uniper exit, targets deal after summer, sources say
Exclusive-Berlin considers full Uniper exit, targets deal after summer, sources say
Jan 13, 2025
LONDON/FRANKFURT (Reuters) - Berlin has sounded out potential buyers for Uniper in a deal that could see the government selling its entire holding in the $18.8 billion energy utility, three people with knowledge of the matter said. Germany's government, which owns 99.12% of the company after nationalising it in 2022 during Europe's energy crisis, is pursuing a partial stake sale,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved